nodes	percent_of_prediction	percent_of_DWPC	metapath
Atovaquone—DHODH—Pyrimidine biosynthesis—TYMS—urinary bladder cancer	0.194	0.238	CbGpPWpGaD
Atovaquone—DHODH—Pyrimidine metabolism—TYMP—urinary bladder cancer	0.142	0.174	CbGpPWpGaD
Atovaquone—DHODH—prostate gland—urinary bladder cancer	0.0743	0.403	CbGeAlD
Atovaquone—DHODH—Pyrimidine metabolism—TYMS—urinary bladder cancer	0.064	0.0784	CbGpPWpGaD
Atovaquone—DHODH—Nucleotide metabolism—TYMP—urinary bladder cancer	0.0552	0.0676	CbGpPWpGaD
Atovaquone—DHODH—Nucleotide metabolism—RRM2—urinary bladder cancer	0.0431	0.0528	CbGpPWpGaD
Atovaquone—DHODH—female reproductive system—urinary bladder cancer	0.0406	0.22	CbGeAlD
Atovaquone—CYP2C9—urine—urinary bladder cancer	0.0382	0.207	CbGeAlD
Atovaquone—DHODH—Nucleotide metabolism—TYMS—urinary bladder cancer	0.0249	0.0306	CbGpPWpGaD
Atovaquone—DHODH—lymph node—urinary bladder cancer	0.0237	0.129	CbGeAlD
Atovaquone—DHODH—Nucleotide metabolism—GPX1—urinary bladder cancer	0.0236	0.0289	CbGpPWpGaD
Atovaquone—CYP2C9—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.0194	0.0238	CbGpPWpGaD
Atovaquone—CYP2C9—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.0158	0.0193	CbGpPWpGaD
Atovaquone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—urinary bladder cancer	0.0151	0.0185	CbGpPWpGaD
Atovaquone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.0119	0.0146	CbGpPWpGaD
Atovaquone—CYP2C9—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00874	0.0107	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GSTZ1—urinary bladder cancer	0.00872	0.0107	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GSTO2—urinary bladder cancer	0.00827	0.0101	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—NAT1—urinary bladder cancer	0.00827	0.0101	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—UGT2B7—urinary bladder cancer	0.00756	0.00927	CbGpPWpGaD
Atovaquone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00756	0.00926	CbGpPWpGaD
Atovaquone—CYP2C9—female reproductive system—urinary bladder cancer	0.00748	0.0406	CbGeAlD
Atovaquone—CYP2C9—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00746	0.00914	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CYP4B1—urinary bladder cancer	0.00681	0.00835	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—SLC19A1—urinary bladder cancer	0.00643	0.00788	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PRSS3—urinary bladder cancer	0.00627	0.00768	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00613	0.00751	CbGpPWpGaD
Atovaquone—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.0061	0.00748	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—TYMP—urinary bladder cancer	0.00501	0.00614	CbGpPWpGaD
Atovaquone—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00465	0.0057	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—NAT2—urinary bladder cancer	0.00453	0.00555	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	0.00417	0.00511	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00411	0.00504	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.00395	0.00484	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.00395	0.00484	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—RRM2—urinary bladder cancer	0.00391	0.00479	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.0039	0.00478	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—HPGDS—urinary bladder cancer	0.00362	0.00444	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—ENO2—urinary bladder cancer	0.00362	0.00444	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.00361	0.00443	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00356	0.00437	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GSTT1—urinary bladder cancer	0.00351	0.00431	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.00325	0.00399	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00321	0.00393	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—NQO1—urinary bladder cancer	0.00292	0.00358	CbGpPWpGaD
Atovaquone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.0028	0.00344	CbGpPWpGaD
Atovaquone—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00275	0.00337	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GSTP1—urinary bladder cancer	0.00244	0.00299	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—TYMS—urinary bladder cancer	0.00226	0.00278	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GSTM1—urinary bladder cancer	0.00224	0.00274	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—NCOR1—urinary bladder cancer	0.00224	0.00274	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.00216	0.00265	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GPX1—urinary bladder cancer	0.00214	0.00263	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00214	0.00262	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—ERCC2—urinary bladder cancer	0.0021	0.00258	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—MTHFR—urinary bladder cancer	0.00198	0.00242	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.00173	0.00212	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.00168	0.00206	CbGpPWpGaD
Atovaquone—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00162	0.00199	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PPARG—urinary bladder cancer	0.0016	0.00197	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CREBBP—urinary bladder cancer	0.00154	0.00189	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PTGS2—urinary bladder cancer	0.00126	0.00155	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00125	0.00153	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.00116	0.00143	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00115	0.00141	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PTEN—urinary bladder cancer	0.0011	0.00135	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.00107	0.00131	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00105	0.00129	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—EP300—urinary bladder cancer	0.00105	0.00129	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000713	0.000874	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	0.000676	0.000828	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NAT1—urinary bladder cancer	0.000676	0.000828	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000665	0.000815	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	0.000618	0.000758	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	0.000556	0.000682	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	0.000525	0.000644	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	0.000512	0.000628	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000411	0.000503	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—TYMP—urinary bladder cancer	0.000409	0.000502	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000393	0.000482	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	0.00037	0.000454	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	0.00032	0.000392	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	0.000296	0.000363	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	0.000296	0.000363	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000294	0.000361	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	0.000287	0.000352	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000283	0.000347	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	0.000239	0.000292	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000231	0.000284	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000202	0.000247	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	0.000199	0.000244	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000193	0.000236	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	0.000185	0.000227	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	0.000183	0.000224	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	0.000183	0.000224	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	0.000175	0.000215	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	0.000172	0.000211	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	0.000162	0.000198	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	0.000131	0.000161	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	0.000126	0.000154	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	0.000103	0.000126	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.99e-05	0.00011	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—EP300—urinary bladder cancer	8.57e-05	0.000105	CbGpPWpGaD
